SecBot SecBot
SECBOTREPLAY Home › Report › RCKTW

RCKTW · Gaurav Shah, an officer and director of Rocket Pharmaceuticals, filed a…

ROCKET PHARMACEUTICALS, INC. · 144 filed May 13, 2026 at 15:13 ET

At the news

NEUTRALIMPACT 2/10

144 filed May 13, 2026 at 15:13 ET

Gaurav Shah, an officer and director of Rocket Pharmaceuticals, filed a Form 144 notice of intent to sell 2,728 shares of common stock, with an approximate market value of $9,836. The shares were acquired on May 11, 2026, through restricted stock vesting as compensation. This is a routine, small-dollar sale by an insider to cover tax obligations from equity vesting, with no material impact on the company's outlook.

  • Insider Gaurav Shah (Officer and Director) filed Form 144 to sell 2,728 shares
  • Estimated sale value: $9,836.08
  • Shares acquired on May 11, 2026 via restricted stock vesting (compensation)
  • Sale is to cover tax obligations from vested equity award distribution

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access